WO2012120532A3 - Cyclic short chain pth analog peptides - Google Patents
Cyclic short chain pth analog peptides Download PDFInfo
- Publication number
- WO2012120532A3 WO2012120532A3 PCT/IN2012/000078 IN2012000078W WO2012120532A3 WO 2012120532 A3 WO2012120532 A3 WO 2012120532A3 IN 2012000078 W IN2012000078 W IN 2012000078W WO 2012120532 A3 WO2012120532 A3 WO 2012120532A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- short chain
- analog peptides
- pth analog
- cyclic
- cyclic short
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention provides novel cyclic short-chain peptideshaving pharmaceutically beneficial properties. The invention also provides a process for preparing such short chain peptides and pharmaceutical compositions containing the cyclic peptides of the present invention. A-Z 1-Z2-Z3-Z4-Z5-Z6-Z7-Z8-Z9-Z10-Z11-Z 12-Z13-Z 14-Z 15-B (I)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN301MU2011 | 2011-02-02 | ||
| IN301/MUM/2011 | 2011-02-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012120532A2 WO2012120532A2 (en) | 2012-09-13 |
| WO2012120532A3 true WO2012120532A3 (en) | 2013-03-14 |
Family
ID=46579272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2012/000078 Ceased WO2012120532A2 (en) | 2011-02-02 | 2012-02-02 | Cyclic short chain peptides |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012120532A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113736741A (en) * | 2021-08-18 | 2021-12-03 | 上海市食品药品检验研究院 | A cloned cell line for determining the biological activity of teriparatide |
| CN115925802B (en) * | 2023-02-22 | 2024-07-23 | 西南交通大学 | Antibacterial peptide with enhanced antibacterial activity and serum stability and application thereof |
| WO2025250872A1 (en) * | 2024-05-31 | 2025-12-04 | Florida Atlantic University Board Of Trustees | Antibody complementary determining region of heavy chain 3 mimics and methods of use thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004067021A1 (en) * | 2003-01-24 | 2004-08-12 | Gardella Thomas J | Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges |
| WO2008068487A1 (en) * | 2006-12-08 | 2008-06-12 | Zealand Pharma A/S | Truncated pth peptides with a cyclic conformation |
| WO2010128521A2 (en) * | 2009-04-24 | 2010-11-11 | Cadila Healthcare Limited | Short-chain peptides as parathyroid hormone (pth) receptor agonist |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1447600A (en) | 1998-10-22 | 2000-05-08 | Thomas J. Gardella | Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) |
| CA2454275C (en) | 2001-07-23 | 2012-10-23 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
| AU2002951372A0 (en) | 2002-09-13 | 2002-09-26 | St Vincent's Institute Of Medical Research | Parathyroid hormone-like polypeptides |
| US7795220B2 (en) | 2003-03-19 | 2010-09-14 | The General Hospital Corporation | Conformationally constrained parathyroid hormones with alpha-helix stabilizers |
| WO2005009358A2 (en) | 2003-07-17 | 2005-02-03 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
| WO2005077918A1 (en) | 2004-02-11 | 2005-08-25 | Smithkline Beecham Corporation | Pth agonists |
| WO2005077959A1 (en) | 2004-02-11 | 2005-08-25 | Smithkline Beecham Corporation | Pth agonists |
| ITMI20041440A1 (en) | 2004-07-19 | 2004-10-19 | Abiogen Pharma Spa | ANALOGUE PEPTIDES OF PTH-1-11 |
| WO2007130113A2 (en) | 2005-09-06 | 2007-11-15 | Zelos Therapeutics, Inc. | Parathyroid hormone analogues and methods of use |
-
2012
- 2012-02-02 WO PCT/IN2012/000078 patent/WO2012120532A2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004067021A1 (en) * | 2003-01-24 | 2004-08-12 | Gardella Thomas J | Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges |
| WO2008068487A1 (en) * | 2006-12-08 | 2008-06-12 | Zealand Pharma A/S | Truncated pth peptides with a cyclic conformation |
| WO2010128521A2 (en) * | 2009-04-24 | 2010-11-11 | Cadila Healthcare Limited | Short-chain peptides as parathyroid hormone (pth) receptor agonist |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012120532A2 (en) | 2012-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011086093A3 (en) | Pharmaceutical compositions for oral administration of insulin peptides | |
| MY161773A (en) | Amylin analogues and pharmaceutical compositions thereof | |
| WO2011138281A3 (en) | Process for the preparation of dithiine tetracarboxydiimides | |
| MX339533B (en) | Dac hyp compositions and methods. | |
| PH12014501162A1 (en) | Aryl dihydropyridinone and piperidinone as mgat2 inhibitors | |
| WO2011157721A3 (en) | Ivabradine-containing pharmaceutical composition | |
| WO2010092090A3 (en) | Novel salts of sitagliptin | |
| WO2012047656A8 (en) | Lipid a analog compositions | |
| ZA201301463B (en) | Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same | |
| IL222999A (en) | Process for the preparation of pleuromutilins, intermediates and pharmaceutical compositions comprising pleuromutilin compounds | |
| WO2013055684A8 (en) | Rasagiline citramide | |
| WO2013080217A3 (en) | Crystalline forms of carbazitaxel and process for preparation thereof | |
| MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| WO2012070062A3 (en) | Novel polymorph of nilotinib hydrochloride | |
| WO2013093931A3 (en) | Novel prodrugs of phenolic drugs | |
| WO2012131707A3 (en) | Crystalline form of bortezomib, preparation method and pharmaceutical composition there f | |
| WO2013074871A3 (en) | Humanin analogs | |
| WO2012120532A3 (en) | Cyclic short chain pth analog peptides | |
| PH12013500210A1 (en) | Highly crystalline valsartan | |
| WO2013150550A3 (en) | An improved process for the preparation of carbapenem antibiotic | |
| MX343701B (en) | Process for alkynylating 16-substituted-17-keto steroids. | |
| MX2013012773A (en) | Drug substances, pharmeceutical compositions and methods for preparing the same. | |
| AU2009235968A8 (en) | Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these | |
| WO2012168680A8 (en) | Pharmaceutical preparation comprising recombinant fsh | |
| MY181682A (en) | Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12738621 Country of ref document: EP Kind code of ref document: A2 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12738621 Country of ref document: EP Kind code of ref document: A2 |